PMID- 33780157 OWN - NLM STAT- MEDLINE DCOM- 20211130 LR - 20211130 IS - 1756-185X (Electronic) IS - 1756-1841 (Linking) VI - 24 IP - 5 DP - 2021 May TI - Association of F11R polymorphisms and gene expression with primary Sjogren's syndrome patients. PG - 681-686 LID - 10.1111/1756-185X.14095 [doi] AB - AIMS: F11R gene encodes junctional adhesion molecule-A protein (JAM-A), which is expressed in various types of cells and is involved in leukocyte extravasation during inflammation. Sjogren's syndrome (SS) is a chronic systemic inflammatory disease that involves lymphocytes invasion of exocrine glands. F11R has been studied in autoimmune diseases, but any association between F11R and SS has not yet been investigated. Therefore, experiments were undertaken to examine the relationships among F11R gene polymorphism, messenger RNA (mRNA) expression and SS patients. METHODS: Three hundred and twenty-nine patients with SS, and 223 healthy controls were enrolled in their recruitment from the Kaohsiung Medical University Hospital. Genomic DNA was extracted from peripheral blood mononuclear cells and gene polymorphisms were genotyped by TaqMan real-time polymerase chain reaction (PCR). F11R mRNA expression was quantitated by quantitative real-time PCR with TaqMan Gene Expression Assay. RESULTS: Our study showed the genotype -688A/C (rs6695707) was not found in relation to SS patients. The odds ratio of -436A/G (rs12567886) genotype was notably associated with less susceptibility of SS in human leukocyte antigen (HLA)-DR2 negative and HLA-DR3 negative individuals. F11R mRNA expression was lower in SS patients than in the cells of healthy controls. CONCLUSION: The result indicated that G allele of -436A/G genotype has the potential protective effect against SS disease condition. F11R mRNA was expressed significantly lower in SS patients. CI - (c) 2021 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd. FAU - Fang, Tzu-Jung AU - Fang TJ AUID- ORCID: 0000-0002-7318-5152 AD - Division of Geriatrics and Gerontology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. AD - Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. FAU - Li, Ruei-Nian AU - Li RN AD - Department of Biomedical Science and Environmental Biology, College of Life Science, Kaohsiung Medical University, Kaohsiung, Taiwan. FAU - Lin, Yuan-Zhao AU - Lin YZ AD - Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. FAU - Lin, Chia-Hui AU - Lin CH AD - Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. FAU - Tseng, Chia-Chun AU - Tseng CC AD - Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. AD - Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. FAU - Sung, Wan-Yu AU - Sung WY AD - Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. FAU - Ou, Tsan-Teng AU - Ou TT AD - Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. FAU - Wu, Cheng-Chin AU - Wu CC AD - Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. FAU - Yen, Jeng-Hsien AU - Yen JH AD - Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. AD - Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. AD - Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan. AD - Department of Biological Science and Technology, National Chiao-Tung University, Hsinchu, Taiwan. LA - eng GR - KMUH102-2M14/Kaohsiung Medical University Chung-Ho Memorial Hospital/ PT - Journal Article DEP - 20210329 PL - England TA - Int J Rheum Dis JT - International journal of rheumatic diseases JID - 101474930 RN - 0 (Cell Adhesion Molecules) RN - 0 (F11R protein, human) RN - 0 (HLA-DR2 Antigen) RN - 0 (HLA-DR3 Antigen) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Cell Surface) RN - EC 2.7.7.- (Taq Polymerase) SB - IM MH - Adult MH - Alleles MH - Case-Control Studies MH - Cell Adhesion Molecules/*genetics MH - Female MH - Gene Expression MH - Genotype MH - HLA-DR2 Antigen MH - HLA-DR3 Antigen MH - Humans MH - Male MH - Middle Aged MH - Polymorphism, Genetic MH - RNA, Messenger/*genetics MH - Real-Time Polymerase Chain Reaction MH - Receptors, Cell Surface/*genetics MH - Sjogren's Syndrome/blood/diagnosis/*genetics/immunology MH - Taq Polymerase EDAT- 2021/03/30 06:00 MHDA- 2021/12/01 06:00 CRDT- 2021/03/29 13:54 PHST- 2021/02/08 00:00 [revised] PHST- 2020/10/29 00:00 [received] PHST- 2021/02/18 00:00 [accepted] PHST- 2021/03/30 06:00 [pubmed] PHST- 2021/12/01 06:00 [medline] PHST- 2021/03/29 13:54 [entrez] AID - 10.1111/1756-185X.14095 [doi] PST - ppublish SO - Int J Rheum Dis. 2021 May;24(5):681-686. doi: 10.1111/1756-185X.14095. Epub 2021 Mar 29.